#USA #New York #Levi & Korsinsky #securities lawsuit #Kyverna Therapeutics

Kyverna Therapeutics Shareholders Legal Alert

Investors in Kyverna Therapeutics, Inc. (NASDAQ: KYTX) should be aware of a class action lawsuit currently in motion, organized by Levi & Korsinsky, LLP. This lawsuit seeks justice for shareholders who have sustained losses due to alleged securities fraud. The critical deadline for shareholders who wish to be recognized as lead plaintiffs is February 7, 2025, which is swiftly approaching.

Understanding the Lawsuit

The class action lawsuit targets all individuals and entities that purchased or otherwise acquired shares of Kyverna Therapeutics’ common stock during the initial public offering (IPO) period in February 2024. The complaint alleges that the company misled investors by failing to disclose crucial information regarding its financial strategies, the IPO terms, and the overall condition of its business.

The specifics alleged include false statements related to:

• - The optimal strategy for conducting the IPO
• - Pricing of common stock during the IPO
• - The content and accuracy of the Offering Documents presented to investors
• - Disclosures intended for the SEC

The lawsuit stresses that the underwriter defendants should have been aware of the issues plaguing Kyverna prior to the IPO and yet chose to issue materially misleading statements that negatively affected shareholders. This misrepresentation has unfortunately led to significant financial losses for many investors.

Next Steps for Shareholders

If you are a shareholder of Kyverna and believe you have experienced a loss related to the company's IPO, you must act quickly. To have a voice in the legal proceedings, you have to submit your request to be appointed as lead plaintiff before the deadline on February 7, 2025. It’s important to note that participating in this process does not require upfront costs or fees—class members may be entitled to compensation without any obligations.

Choosing Levi & Korsinsky

Levi & Korsinsky stands out in the landscape of securities litigation owing to their proven track record. With over 20 years of experience, the firm has recovered hundreds of millions of dollars for investors. Their dedicated team focuses on complex securities issues and strives to protect shareholder interests aggressively. The firm has been consistently ranked in the top echelons of securities litigation firms as recognized by ISS Securities Class Action Services.

Contact Information

For further inquiries, shareholders can reach out to Joseph E. Levi, Esq. or Ed Korsinsky, Esq. via email or by phone. Details are as follows:

• - Email: inquiries@zlk.com
• - Phone: (212) 363-7500
• - Law Firm Address: 33 Whitehall Street, 17th Floor, New York, NY 10004

Conclusion

As the February deadline looms, it’s imperative for affected shareholders to understand their rights and options. The action taken now can determine the outcome of potential recoveries in the future. Investors should not hesitate to gather more information and consider participating in this vital lawsuit to seek the justice they deserve.